We are live on ! Find out more
UTHR icon

United Therapeutics

400 hedge funds and large institutions have $6.44B invested in United Therapeutics in 2017 Q4 according to their latest regulatory filings, with 62 funds opening new positions, 135 increasing their positions, 139 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

94% more first-time investments, than exits

New positions opened: 62 | Existing positions closed: 32

50% more funds holding in top 10

Funds holding in top 10: 46 (+2)

26% more capital invested

Capital invested by funds: $5.13B → $6.44B (+$1.31B)

7% more funds holding

Funds holding: 373400 (+27)

0.49% more ownership

Funds ownership: 100.54%101.03% (+0.49%)

3% less repeat investments, than reductions

Existing positions increased: 135 | Existing positions reduced: 139

11% less call options, than puts

Call options by funds: $20.4M | Put options by funds: $23M

Holders
400
Holders Change
+27
Holders Change %
+7.24%
% of All Funds
9.07%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.14%
New
62
Increased
135
Reduced
139
Closed
32
Calls
$20.4M
Puts
$23M
Net Calls
-$2.55M
Net Calls Change
-$45.6M
Name Holding Trade Value Shares
Change
Change in
Stake
Citigroup
51
Citigroup
New York
$19.4M +$4.16M +32,711 +33%
Sumitomo Mitsui Trust Group
52
Sumitomo Mitsui Trust Group
Japan
$18.4M +$460K +3,621 +3%
Capital Fund Management (CFM)
53
Capital Fund Management (CFM)
France
$18.3M +$7.95M +62,524 +102%
BC
54
Burney Company
Virginia
$17.8M +$445K +3,499 +3%
UBS AM
55
UBS AM
Illinois
$17.7M -$672K -5,288 -4%
CS
56
Credit Suisse
Switzerland
$17.5M +$1.77M +13,947 +13%
PAMU
57
Pictet Asset Management (UK)
United Kingdom
$17.2M +$2.14M +16,828 +17%
New York State Common Retirement Fund
58
New York State Common Retirement Fund
New York
$16.2M +$208K +1,640 +2%
Bank of Montreal
59
Bank of Montreal
Ontario, Canada
$15.8M +$4.73M +37,207 +53%
Canada Life
60
Canada Life
Manitoba, Canada
$15.3M -$3.3M -25,956 -20%
GC
61
Guggenheim Capital
Illinois
$15.3M +$1.61M +12,694 +14%
Bank of America
62
Bank of America
North Carolina
$14.9M -$1.24M -9,717 -9%
BA
63
Bridgewater Associates
Connecticut
$13.9M +$121K +953 +1%
Mitsubishi UFJ Trust & Banking
64
Mitsubishi UFJ Trust & Banking
Japan
$13.8M +$601K +4,728 +5%
Legal & General Group
65
Legal & General Group
United Kingdom
$13.6M +$241K +1,896 +2%
AIG
66
American International Group
New York
$13.5M +$66.6K +524 +0.6%
VRS
67
Virginia Retirement Systems
Virginia
$12.8M -$2.64M -20,800 -19%
RhumbLine Advisers
68
RhumbLine Advisers
Massachusetts
$12.8M -$189K -1,489 -2%
Connor, Clark & Lunn Investment Management (CC&L)
69
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$11.9M -$1.59M -12,483 -13%
California State Teachers Retirement System (CalSTRS)
70
California State Teachers Retirement System (CalSTRS)
California
$11.9M +$847K +6,662 +9%
VanEck Associates
71
VanEck Associates
New York
$11.7M -$5.56M -43,717 -36%
New York State Teachers Retirement System (NYSTRS)
72
New York State Teachers Retirement System (NYSTRS)
New York
$11.6M
Asset Management One
73
Asset Management One
Japan
$11.2M -$897K -7,057 -9%
GT
74
Glenmede Trust
Pennsylvania
$11.2M -$232K -1,826 -2%
TA
75
Teachers Advisors
New York
$11.1M +$1.13M +8,864 +13%

UTHR Hedge Fund Activity: Q4 2017 in Review

400 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in United Therapeutics (UTHR) for Q4 2017, worth a combined $6.44B — up 26% from $5.13B a quarter earlier.

Buyers outnumbered sellers: 62 funds opened new UTHR positions and 32 closed out — a net gain of 30 holders — while 135 added to existing stakes and 139 trimmed.

The largest buyer was Skandinaviska Enskilda Banken (SEB), adding an estimated $47.1M. The largest seller was Morgan Stanley, cutting an estimated $43.6M.

  • 400 institutional investors held United Therapeutics (UTHR) as of Q4 2017, up from 373 in Q3 2017.
  • Funds reported $6.44B of United Therapeutics stock for Q4 2017, up 26% quarter-over-quarter.
  • 62 funds opened new United Therapeutics positions in Q4 2017 and 32 closed out, a net change of +30 holders.
  • The largest United Therapeutics buyer in Q4 2017 was Skandinaviska Enskilda Banken (SEB), an estimated $47.1M added.
  • The largest United Therapeutics seller in Q4 2017 was Morgan Stanley, an estimated $43.6M sold.

Based on aggregated 13F filings for Q4 2017.